A detailed history of Aldebaran Capital, LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Aldebaran Capital, LLC holds 100,500 shares of ANTX stock, worth $100,500. This represents 0.1% of its overall portfolio holdings.

Number of Shares
100,500
Holding current value
$100,500
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.98 - $2.96 $98,490 - $297,480
100,500 New
100,500 $108 Million

Others Institutions Holding ANTX

About AN2 Therapeutics, Inc.


  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $19.4M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Aldebaran Capital, LLC Portfolio

Follow Aldebaran Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aldebaran Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aldebaran Capital, LLC with notifications on news.